131 related articles for article (PubMed ID: 15763138)
1. Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation.
Yatin SM; Miller GM; Madras BK
J Neurosci Methods; 2005 Apr; 143(1):69-78. PubMed ID: 15763138
[TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter-dependent induction of C-Fos in HEK cells.
Yatin SM; Miller GM; Norton C; Madras BK
Synapse; 2002 Jul; 45(1):52-65. PubMed ID: 12112414
[TBL] [Abstract][Full Text] [Related]
3. Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
Shimazu S; Tsunekawa H; Yoneda F; Katsuki H; Akaike A; Janowsky A
Eur J Pharmacol; 2003 Dec; 482(1-3):9-16. PubMed ID: 14659999
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
Syringas M; Janin F; Giros B; Costentin J; Bonnet JJ
Br J Pharmacol; 2001 Jun; 133(3):387-94. PubMed ID: 11375255
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein.
Chang MY; Lee SH; Kim JH; Lee KH; Kim YS; Son H; Lee YS
J Neurochem; 2001 May; 77(3):754-61. PubMed ID: 11331404
[TBL] [Abstract][Full Text] [Related]
8. Delineation of an endogenous zinc-binding site in the human dopamine transporter.
Norregaard L; Frederiksen D; Nielsen EO; Gether U
EMBO J; 1998 Aug; 17(15):4266-73. PubMed ID: 9687495
[TBL] [Abstract][Full Text] [Related]
9. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
Kahlig KM; Javitch JA; Galli A
J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
[TBL] [Abstract][Full Text] [Related]
10. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
[TBL] [Abstract][Full Text] [Related]
11. N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization.
Granas C; Ferrer J; Loland CJ; Javitch JA; Gether U
J Biol Chem; 2003 Feb; 278(7):4990-5000. PubMed ID: 12464618
[TBL] [Abstract][Full Text] [Related]
12. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
Wersinger C; Vernier P; Sidhu A
Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560
[TBL] [Abstract][Full Text] [Related]
13. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution.
Garcia BG; Wei Y; Moron JA; Lin RZ; Javitch JA; Galli A
Mol Pharmacol; 2005 Jul; 68(1):102-9. PubMed ID: 15795321
[TBL] [Abstract][Full Text] [Related]
14. Conventional protein kinase C isoforms regulate human dopamine transporter activity in Xenopus oocytes.
Doolen S; Zahniser NR
FEBS Lett; 2002 Apr; 516(1-3):187-90. PubMed ID: 11959130
[TBL] [Abstract][Full Text] [Related]
15. Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.
Houlihan WJ; Kelly L; Pankuch J; Koletar J; Brand L; Janowsky A; Kopajtic TA
J Med Chem; 2002 Sep; 45(19):4097-109. PubMed ID: 12213053
[TBL] [Abstract][Full Text] [Related]
16. Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta.
Johnson LA; Guptaroy B; Lund D; Shamban S; Gnegy ME
J Biol Chem; 2005 Mar; 280(12):10914-9. PubMed ID: 15647254
[TBL] [Abstract][Full Text] [Related]
17. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
Apparsundaram S; Schroeter S; Giovanetti E; Blakely RD
J Pharmacol Exp Ther; 1998 Nov; 287(2):744-51. PubMed ID: 9808705
[TBL] [Abstract][Full Text] [Related]
18. Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function.
Strauss MJ; Porter KD; Quizon PM; Davis SE; Lin S; Yuan Y; Martinez-Muniz GA; Sun WL; Zhan CG; Zhu J
PLoS One; 2022; 17(9):e0275182. PubMed ID: 36170295
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.
Morón JA; Zakharova I; Ferrer JV; Merrill GA; Hope B; Lafer EM; Lin ZC; Wang JB; Javitch JA; Galli A; Shippenberg TS
J Neurosci; 2003 Sep; 23(24):8480-8. PubMed ID: 13679416
[TBL] [Abstract][Full Text] [Related]
20. Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes.
Zhu SJ; Kavanaugh MP; Sonders MS; Amara SG; Zahniser NR
J Pharmacol Exp Ther; 1997 Sep; 282(3):1358-65. PubMed ID: 9316847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
